Webinar: Cancer as an Epigenetic Disease: The Role of Epigenetic Transformation and Regulatory Switches

Join our upcoming epigenetics webinar and gain insights from leading experts on how epigenetic mechanisms shape cellular identity and influence oncogenesis. Link will be provided with the confirmation email. 

Register here       Learn more about Zymo Research

About this webinar

Epigenetics is increasingly recognised as a driving force in both health and disease, from early development to cancer.
In this exclusive session, Prof. Dr. Alexander Meissner (Max Planck Institute for Molecular Genetics, Berlin) will share his insights into the role of epigenetic mechanisms in shaping cellular identity and their impact on oncogenesis.

His research focuses on the regulation of the genome and epigenome during early mammalian development, pluripotency, and reprogramming, with a particular emphasis on DNA methylation dynamics and the interplay of repressive pathways. A major theme of his current work is understanding parallels between developmental and cancer epigenomes, including how stable epigenetic states and CpG island regulation contribute to oncogenesis.

Complementing this, Dr. Xiaojing Yang, Head of R&D Epigenetics at Zymo Research, will present how Zymo Research’s innovative solutions empower researchers to explore, decode, and translate epigenetic regulation into scientific and therapeutic advances.

Key topics

Attendees will learn:

• Which epigenetic alterations beyond genetic mutations define tumour initiation and progression.

• How cancer shares conserved epigenomic features across patient tumours, xenografts, cell lines, and organoid models.

• Why cancer may represent an epigenetic state transition, challenging the classical somatic to cancer paradigm.

Speakers

Prof. Dr. Alexander Meissner
Director of Genome Regulation at the Max Planck Institute for Molecular Genetics, Berlin

Xiaojing Yang, PhD
Group Leader Epigenetics at Zymo Research Corp.